Paolo Tarantino: A pleasure to co-host the latest ESMO Open podcast with Giuseppe Curigliano

Paolo Tarantino shared a post by ESMO – European Society for Medical Oncology on LinkedIn, adding:

”Don’t miss the latest ESMO Open podcast, with Sara Hurvitz and Nancy Lin discussing the latest data on the intracranial activity of ADCs for metastatic breast cancer. A pleasure to co-host the podcast with Giuseppe Curigliano.”

Quoting ESMO – European Society for Medical Oncology’s post:

”Latest podcast ESMO Open Editor-in-Chief Giuseppe Curgliano presents a discussion between Sara Hurwitz and Nancy Lin, with ESMO Open Associate Editor Paolo Tarantino, following the publication of their articles on antibody-drug conjugate activity in patients with HER2-positive breast cancer.”

Source: Paolo Tarantino/LinkedIn and ESMO – European Society for Medical Oncology/LinkedIn

Dr. Paolo Tarantino, MD researcher, holds positions at both the European Institute of Oncology in Milan, Italy, and the Dana-Farber Cancer Institute in Boston, MA, Specializing in breast cancer. Currently, Dr. Tarantino is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan. His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a robust publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field. Dr. Tarantino’s dedication and innovative approach contribute significantly to the advancement of breast cancer treatment and research.